Newsletter | April 30, 2025

04.30.25 -- How Much Should Startups Ask For?

NEW PODCAST EPISODE

The Implications Of China's Growing Biotech Industry With Allan Shaw

Business of Biotech MVP, Allan Shaw, discusses China's biotech rise from follower to innovator, with increased deal activity and faster trials challenging Western models, despite U.S.-China policy uncertainty. Listen now and subscribe so you never miss an episode!

FEATURED ARTICLE

Securing Capital At The Right Moment: How Much Should Startups Ask For?

When funding is tight, life sciences startups must be even more strategic with requested amounts, timing, and funding sources, explains Michael Brooder.

INDUSTRY INSIGHTS

Continued Growth In Pharma R&D For 2025

Explore this breakdown of the key findings in Citeline's full Pharma R&D Annual Review 2025 through easy-to-understand graphs and charts that highlight trends in the R&D pipeline.

Identify And Quantify AAV Fill States Using Analytical Ultracentrifugation

Discover how to implement analysis using sedimentation velocity analytical ultracentrifugation to characterize AAV size distributions and multiple detection wavelengths to identify various fill states.

6 Strategies To Engage Rare Disease PAOs Effectively

Patient advocacy organizations (PAOs) play a pivotal role in rare disease research by bridging the gap between patient communities and biotech companies.

Maximizing Clinical Data Insights With Advanced Analytics Platforms

To achieve drug approval, trials must collect, combine, and analyze diverse data sets that support operational, safety review, risk management, and other analyses crucial to development.

Maintaining Drug Bioavailability And Masking Taste With Microencapsulation

Several technologies are available for microencapsulating drugs. Finding the right CDMO to optimize a drug’s efficacy and manufacturing during formulation is integral to its clinical and commercial success.